Shankar Vallabhajosula

Company: Convergent Therapeutics, Inc

Job title: Vice President, Radiopharmaceutical Sciences

Seminars:

Optimizing Radiopharmaceutical Drug Design: Evaluating Approved Therapies & Exploring Novel Chelator & Linker Approaches 11:30 am

Exploring the advantages and disadvantages of target vehicles (such as small molecules, peptides, and antibodies) Outlining lessons learned from the current approved radiopharmaceuticals. Selection of radionuclides and chelating agents for the development of radiopharmaceuticals for theranostics (imaging and therapy)Read more

day: Conference Day Two